LOADING
Comparing Tesla Inc (TSLA) and AbbVie Inc (ABBV) across the Consumer Discretionary and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TSLA | ABBV |
|---|---|---|
| Price | $431.28 | $210.77 |
| Change Today | -2.71% | +1.09% |
| Market Cap | $1.66T | $368.4B |
| P/E Ratio | 399.4 | 102.2 |
| Forward P/E | 208.3 | 14.1 |
| PEG Ratio | 5.90 | 0.56 |
| EPS | $1.11 | $2.04 |
| Revenue Growth (YoY) | 15.8% | 12.4% |
| Profit Margin | 4.0% | 5.8% |
| Return on Equity | 4.9% | 62.3% |
| Dividend Yield | -- | 3.24% |
| Beta | 1.79 | 0.30 |
| 52-Week High | $498.83 | $239.13 |
| 52-Week Low | $273.21 | $174.56 |
| Volume | 10 | 5.0M |
Tesla Inc is the larger company by market capitalization. AbbVie Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.